2.85
price down icon3.39%   -0.10
after-market 시간 외 거래: 2.89 0.04 +1.40%
loading
전일 마감가:
$2.95
열려 있는:
$2.99
하루 거래량:
2.57M
Relative Volume:
0.73
시가총액:
$755.66M
수익:
$194.75M
순이익/손실:
$-51.26M
주가수익비율:
-10.18
EPS:
-0.28
순현금흐름:
$-23.38M
1주 성능:
+6.34%
1개월 성능:
-8.95%
6개월 성능:
+69.64%
1년 성능:
+115.91%
1일 변동 폭
Value
$2.83
$3.02
1주일 범위
Value
$2.66
$3.02
52주 변동 폭
Value
$1.255
$4.0787

Akebia Therapeutics Inc Stock (AKBA) Company Profile

Name
명칭
Akebia Therapeutics Inc
Name
전화
617-871-2098
Name
주소
245 FIRST STREET, CAMBRIDGE, MA
Name
직원
181
Name
트위터
@akebiatx
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
AKBA's Discussions on Twitter

AKBA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
AKBA
Akebia Therapeutics Inc
2.85 782.18M 194.75M -51.26M -23.38M -0.28
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.49 63.27B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.31 45.67B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.04 39.27B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.21 23.02B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
448.93 20.66B 3.08B 1.24B 1.07B 25.61

Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-04 재개 H.C. Wainwright Buy
2025-04-28 개시 Leerink Partners Outperform
2025-04-01 개시 Jefferies Buy
2023-11-29 재개 BTIG Research Buy
2023-08-28 업그레이드 H.C. Wainwright Neutral → Buy
2023-05-31 업그레이드 Piper Sandler Neutral → Overweight
2022-03-31 다운그레이드 H.C. Wainwright Buy → Neutral
2022-03-31 다운그레이드 Mizuho Buy → Neutral
2022-03-31 다운그레이드 Needham Buy → Hold
2022-03-31 다운그레이드 Piper Sandler Overweight → Neutral
2021-03-08 개시 Cantor Fitzgerald Overweight
2021-01-29 다운그레이드 JP Morgan Neutral → Underweight
2019-11-14 재확인 Needham Buy
2019-08-06 재확인 H.C. Wainwright Buy
2019-07-11 재확인 H.C. Wainwright Buy
2019-05-02 개시 JP Morgan Overweight
2019-03-20 개시 Citigroup Neutral
2018-09-07 재개 Morgan Stanley Equal-Weight
2018-08-10 재확인 Needham Buy
2018-06-06 재확인 H.C. Wainwright Buy
2017-12-19 개시 Piper Jaffray Overweight
2017-12-07 개시 BTIG Research Buy
2017-09-15 개시 RBC Capital Mkts Sector Perform
2017-07-10 재확인 H.C. Wainwright Buy
2017-04-27 재확인 H.C. Wainwright Buy
2017-04-27 재확인 Needham Buy
2016-12-27 재확인 H.C. Wainwright Buy
2016-12-20 재확인 JMP Securities Mkt Outperform
2016-11-15 개시 Aegis Capital Buy
2016-09-29 개시 Brean Capital Buy
2016-03-16 재확인 Needham Buy
2016-01-21 개시 Credit Suisse Neutral
모두보기

Akebia Therapeutics Inc 주식(AKBA)의 최신 뉴스

pulisher
03:01 AM

Weiss Ratings Reiterates Sell (D-) Rating for Akebia Therapeutics (NASDAQ:AKBA) - MarketBeat

03:01 AM
pulisher
09:40 AM

Is Intellia Therapeutics (NTLA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

09:40 AM
pulisher
Oct 07, 2025

Akebia Therapeutics Achieves Multibagger Status with 123.31% Stock Increase Over Past Year - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Profit Outlook - simplywall.st

Oct 07, 2025
pulisher
Oct 06, 2025

What drives Akebia Therapeutics Inc stock priceInsider Buying Signals & Free Daily Market Summary and Trend Reports - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Can Akebia Therapeutics Inc. (AX9) stock resist broad market declines2025 Major Catalysts & AI Powered Buy/Sell Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How Akebia Therapeutics Inc. stock performs in interest rate cyclesProduct Launch & Daily Entry Point Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What to expect from Akebia Therapeutics Inc. in the next 30 days2025 Year in Review & Real-Time Stock Price Movement Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How Akebia Therapeutics Inc. stock reacts to inflationary pressuresMarket Weekly Review & Low Drawdown Trading Techniques - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Should I hold or sell Akebia Therapeutics Inc. stock in 2025Trade Volume Summary & Advanced Technical Analysis Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 06:28:34 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Akebia Therapeutics Inc. stock poised for growthRate Hike & Weekly High Conviction Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Akebia Therapeutics Inc. (AX9) stock profit from AI boom2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Leading vs lagging indicators on Akebia Therapeutics Inc. performanceJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why Akebia Therapeutics Inc. (AX9) stock is a strong buy callEarnings Recap Summary & Precise Trade Entry Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Akebia Therapeutics Inc. stock entering bullish territoryJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is Akebia Therapeutics Inc. (AX9) stock attractive for dividend growthWeekly Trend Report & AI Based Trade Execution Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Why ETFs are accumulating Akebia Therapeutics Inc. (AX9) stockProfit Target & Fast Exit/Entry Strategy Plans - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 02, 2025
pulisher
Oct 01, 2025

204,163 Stock Options: Akebia Therapeutics Awards New Employee Grants with 4-Year Vesting Terms - Stock Titan

Oct 01, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 08:27:07 - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Why Akebia Therapeutics Inc. is moving todayTreasury Yields & High Accuracy Trade Signal Alerts - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

How Akebia Therapeutics Inc. (AX9) stock moves in volatile trading sessions2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 03:08:07 - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Atul Ltd (ATUL)’s Trend in 2025Head and Shoulders Patterns & Free Daily Investment Newsletter Subscription - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

Published on: 2025-09-28 22:31:40 - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Will Analyst Upgrades Continue to Fuel Sumeru Industries Limiteds RallyStock Buyback Updates & Free Triple Digit Wealth Increase - Early Times

Sep 28, 2025

Akebia Therapeutics Inc (AKBA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.34
price down icon 0.54%
$9.97
price down icon 1.68%
drug_manufacturers_specialty_generic RDY
$13.99
price down icon 0.29%
$58.17
price up icon 0.35%
$139.08
price up icon 1.52%
$448.93
price down icon 1.73%
자본화:     |  볼륨(24시간):